Výsledky vyhledávání

P11.24 CR13626, an oral tyrosine kinase inhibitor crossing the blood brain barrier, reduces tumour growth and prolongs survival in a mouse model of glioblastoma

Autor: M Montagna, Tiziana Piepoli, O Letari, R Artusi, Milena Colovic, G Caselli, L C Rovati, Chiara Galimberti, S Persiani

Publikováno v: Neuro Oncol

BACKGROUND Glioblastoma multiforme (GBM) is the most malignant primary brain cancer. Several mutations and alterations of key cellular pathways including tyrosine kinases (TKs) are involved in GBM etiopathogenesis. Currently there is no cure for GBM.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4834f76d275d0d2d6d8d5f4af168cb
https://europepmc.org/articles/PMC6796123/

Zobrazit plný text záznamu

Hepatitis C virus dynamics and cellular gene expression in uPA ‐ SCID chimeric mice with humanized livers during intravenous silibinin monotherapy

Autor: Alan S. Perelson, Chise Tateno, Sakura Akamatsu, Harel Dahari, Nobuhiko Hiraga, Michio Imamura, Laetitia Canini, S. Persiani, Susan L. Uprichard, Swati DebRoy, Kazuaki Chayama, Clair Nelson Hayes, Ralf T. Pohl

Publikováno v: Journal of Viral Hepatitis. 23:708-717

Legalon SIL (SIL) is a chemically hydrophilized version of silibinin, an extract of milk thistle (Silybum marianum) seeds that has exhibited hepatoprotective and antiviral effectiveness against hepatitis C virus (HCV) in patients leading to viral cle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33a8f08c579486c0369ab6d1ed1bb33
https://doi.org/10.1111/jvh.12551

Zobrazit plný text záznamu

Plný text ve formátu HTML

Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog

Autor: C, Webber, C A, Stokes, S, Persiani, F, Makovec, A, McBurney, R P, Kapil, B A, John, M, D'Amato, L F, Chasseaud

Publikováno v: European Journal of Drug Metabolism and Pharmacokinetics. 29:15-23

Single oral doses of 14C-dexloxiglumide were rapidly and extensively absorbed in dogs and also eliminated rapidly with a short half-life. Following single intravenous doses, dexloxiglumide was characterised as a drug having a high clearance (30.7 and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd6ea2ba4788240341bfa8fb0d2de1d
https://doi.org/10.1007/bf03190569

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers

Autor: F. Macchi, S. Persiani, M. Bani, G. Moroni, M. Guillaume, A. Colantoni

Publikováno v: British Journal of Clinical Pharmacology. 50:338-349

Aims The objective of this study was to evaluate the tolerability of a novel dual ACE-NEP inhibitor, Z13752A, after the oral administration of rising single doses in healthy volunteers. This study was also a preliminarily investigation of Z13752A pha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37492e1991583c8a466b35837578232c
https://doi.org/10.1046/j.1365-2125.2000.00257.x

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

THE EFFECT OF FOOD ON CABERGOLINE PHARMACOKINETICS AND TOLERABILITY IN HEALTHY VOLUNTEERS

Autor: Margherita Strolin-Benedetti, M. Rocchetti, Steve Toon, Beverly I Holt, S. Persiani, M. A. Pacciarini

Publikováno v: Biopharmaceutics & Drug Disposition. 17:443-455

The effect of food on the pharmacokinetics and tolerability of cabergoline in man was investigated. For this purpose an open, randomized, single-dose study was conducted in 12 healthy male volunteers who received 1 mg cabergoline as tablets both unde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ec22346f770bf6aade6a8d5207ae4c27
https://doi.org/10.1002/(sici)1099-081x(199607)17:5<443::aid-bdd443>3.0.co

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání